Amelioration of Colorectal Cancer Using Negative Lipidoid Nanoparticles to Encapsulate siRNA Against APRIL by Enema Delivery Mode.

This study reveals APRIL to be a potential anti-CRC target by in vivo experiments, and suggests that the application of similar modes of siRNA delivery may be feasible in other therapeutic settings.
PMID: 24771268 [PubMed - as supplied by publisher]

Source: Pathology Oncology Research - April 26, 2014 Category: Pathology Authors: Ding W, Wang G, Shao K, Wang F, Huang H, Ju S, Cong H, Wang H Tags: Pathol Oncol Res Source Type: research